Cargando…
Zinc in the Glutamatergic Theory of Depression
Depression is a serious psychiatric illness that affects millions of people worldwide. Weeks of antidepressant therapy are required to relieve depressive symptoms, and new drugs are still being extensively researched. The latest studies have shown that in depression, there is an imbalance between th...
Autor principal: | Młyniec, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790399/ https://www.ncbi.nlm.nih.gov/pubmed/26412070 http://dx.doi.org/10.2174/1570159X13666150115220617 |
Ejemplares similares
-
The role of GPR39 zinc receptor in the modulation of glutamatergic and GABAergic transmission
por: Starowicz, Gabriela, et al.
Publicado: (2023) -
Interaction between Zinc, GPR39, BDNF and Neuropeptides in Depression
por: Mlyniec, Katarzyna
Publicado: (2021) -
Zinc in the Monoaminergic Theory of Depression: Its Relationship to Neural Plasticity
por: Doboszewska, Urszula, et al.
Publicado: (2017) -
GPR39 (Zinc Receptor) Knockout Mice Exhibit Depression-Like Behavior and CREB/BDNF Down-Regulation in the Hippocampus
por: Młyniec, Katarzyna, et al.
Publicado: (2015) -
Zinc-mediated Neurotransmission in Alzheimer’s Disease: A Potential Role of the GPR39 in Dementia
por: Rychlik, Michal, et al.
Publicado: (2020)